SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-21-004415
Filing Date
2021-04-16
Accepted
2021-04-16 16:20:21
Documents
7
Period of Report
2021-04-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20210416xpre14a.htm PRE 14A 1844319
2 GRAPHIC tmb-20210416xpre14a021.jpg GRAPHIC 5271
3 GRAPHIC tmb-20210416xpre14a003.jpg GRAPHIC 1692
4 GRAPHIC tmb-20210416xpre14a001.jpg GRAPHIC 7588
5 GRAPHIC tmb-20210416xpre14a004.jpg GRAPHIC 39610
6 GRAPHIC tmb-20210416xpre14a002.jpg GRAPHIC 3733
7 GRAPHIC tmb-20210416xpre14a008.jpg GRAPHIC 39677
  Complete submission text file 0001558370-21-004415.txt   1980760
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35969 | Film No.: 21831777
SIC: 2834 Pharmaceutical Preparations